Soliton (SOLY) 10-Q 13 May 19 2019 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2019	May 05, 2019
Document Information [Line Items]
Entity Registrant Name	Soliton, Inc.
Entity Central Index Key	0001548187
Trading Symbol	soly
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	No
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Small Business	true
Entity Common Stock, Shares Outstanding (in shares)		14,678,435
Document Type	10-Q
Document Period End Date	Mar. 31, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 4,860,690	$ 133,435
Restricted cash	200,000
Total cash	5,060,690	133,435
Prepaid expenses and other current assets	230,882	10,533
Total current assets	5,291,572	143,968
Deferred direct issuance costs - proposed offering		276,560
Property and equipment, net of accumulated depreciation	987,967	1,014,240
Intangible assets, net of accumulated amortization	86,080	84,942
Other assets	23,283	23,283
Total assets	6,388,902	1,542,993
Current liabilities:
Accounts payable	546,067	2,737,836
Accrued liabilities	1,360,958	1,863,874
Dividends payable		4,613,260
Accrued interest		133,804
Accrued interest - related party		1,162,719
Convertible notes payable, net	47,781	1,784,976
Convertible notes payable - related party		8,422,000
Notes payable, net		293,568
Notes payable - related party, net		65,479
Deferred rent - current portion	7,106	7,106
Total current liabilities	1,961,912	21,084,622
Deferred rent	15,250	16,256
Total liabilities	1,977,162	21,100,878
Commitments and contingencies (Note 5)
Stockholders’ equity (deficit)
Common stock, $0.001 par value, 100,000,000 authorized, 14,613,000 shares issued and outstanding at March 31, 2019 and 1,998,056 shares issued and outstanding at December 31, 2018	14,613	1,998
Additional paid-in capital	49,896,966	22,568,857
Accumulated deficit	(45,499,839)	(42,131,275)
Total stockholders’ equity (deficit)	4,411,740	(19,557,885)
Total liabilities and stockholders’ equity (deficit)	6,388,902	1,542,993
Series A Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock		417
Series B Preferred Stock [Member]
Stockholders’ equity (deficit)
Preferred stock		$ 2,118

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parentheticals) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Preferred stock, par value (in dollars per share)		$ 0.001
Preferred stock, shares designated (in shares)		2,534,766
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	100,000,000	100,000,000
Common stock, shares issued (in shares)	14,613,000	1,998,056
Common stock, shares outstanding (in shares)	14,613,000	1,998,056
Series A Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, liquidation value	$ 1,999,997	$ 1,999,997
Preferred stock, shares designated (in shares)		416,666
Preferred stock, shares issued (in shares)		416,666
Preferred stock, shares outstanding (in shares)		416,666
Series B Preferred Stock [Member]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, liquidation value	$ 14,000,641	$ 14,000,641
Preferred stock, shares designated (in shares)		2,118,100
Preferred stock, shares issued (in shares)		2,118,100
Preferred stock, shares outstanding (in shares)		2,118,100

Condensed Statements of Operati

Condensed Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Revenue
Operating expenses:
Research and development	445,402	692,725
Sales and marketing	57,016	12,500
Depreciation and amortization	29,703	30,561
General and administrative	1,854,684	449,029
Total operating expenses	2,386,805	1,184,815
Loss from operations	(2,386,805)	(1,184,815)
Other (expense) income:
Interest expense	(822,858)	(166,887)
Interest income	1,318	37
Total other (expense) income	(821,540)	(166,850)
Loss before income taxes	(3,208,345)	(1,351,665)
Income tax (expense) benefit
Net loss	(3,208,345)	(1,351,665)
Dividend to series A and B preferred stockholders	(160,219)	(320,000)
Net loss attributable to common stockholders	$ (3,368,564)	$ (1,671,665)
Net loss per common share, basic and diluted (in dollars per share)	$ (0.43)	$ (0.92)
Weighted average number of common shares outstanding, basic and diluted (in shares)	7,745,378	1,820,556

Statements of Changes in Stockh

Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - 3 months ended Mar. 31, 2019 - USD ($)	Preferred Stock [Member]Series A Preferred Stock [Member]	Preferred Stock [Member]Series B Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2018	416,666	2,118,100	1,998,056
Balance at Dec. 31, 2018	$ 417	$ 2,118	$ 1,998	$ 22,568,857	$ (42,131,275)	$ (19,557,885)
Share-based compensation				512,045		512,045
Debt discount on convertible notes and notes payable – issuance of warrants				145,974		145,974
Payment of deferred direct issuance costs				(186,029)		(186,029)
Issuance of common shares for extinguishment of preferred shares (in shares)	(416,666)	(2,118,100)
Issuance of common shares for extinguishment of preferred shares	$ (417)	$ (2,118)
Conversion of Stock, Shares Issued			2,534,766
Issuance of common shares for extinguishment of preferred shares			$ 2,535
Issuance of common shares for extinguishment of preferred shares
Issuance of common shares for extinguishment of convertible debt (in shares)			6,825,391
Issuance of common shares for extinguishment of convertible debt			$ 6,825	11,778,162		11,784,987
Issuance of common shares for extinguishment of dividends payable (in shares)			954,696
Issuance of common shares for extinguishment of dividends payable			$ 955	4,772,525		4,773,480
Issuance of common shares from IPO, net of costs (in shares)			2,172,591
Issuance of common shares from IPO, net of costs			$ 2,173	9,871,494		9,873,667
Issuance of common shares for accelerated vesting (in shares)			127,500
Issuance of common shares for accelerated vesting			$ 127	(127)
Accrued preferred dividends					(160,219)	(160,219)
Net loss					(3,208,345)	(3,208,345)
Debt forgiveness				434,065		434,065
Balance (in shares) at Mar. 31, 2019			14,613,000
Balance at Mar. 31, 2019			$ 14,613	$ 49,896,966	$ (45,499,839)	$ 4,411,740

Condensed Statements of Cash Fl

Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (3,208,345)	$ (1,351,665)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	29,703	30,561
Share-based compensation	512,045	145,553
Amortization of debt discount	664,953
Deferred rent	(1,006)	125
Changes in operating assets - (Increase)/Decrease:
Prepaid expenses and other current assets	(220,349)	(1,954)
Changes in operating liabilities - Increase/(Decrease):
Accounts payable	(1,941,769)	477,328
Accrued liabilities	(68,853)	(345,802)
Non-convertible accrued interest - non-related and related party	10,617
Convertible accrued interest - related party	145,667	166,857
NET CASH USED IN OPERATING ACTIVITIES:	(4,077,337)	(878,997)
CASH FLOWS FROM INVESTING ACTIVITIES:
Payments for the purchase of property and equipment	(3,430)
Payments for acquisition of intangibles	(1,138)	(3,880)
NET CASH USED IN INVESTING ACTIVITIES:	(4,568)	(3,880)
CASH FLOWS FROM FINANCING ACTIVITIES:
Payment of non-convertible notes payable - related party and non-related party	(985,000)
Payment of non-convertible notes payable accrued interest - related party and non-related party	(20,038)
Proceeds from the issuance of non-convertible notes payable - non-related party	300,000
Proceeds from initial public offering	9,714,198
Proceeds from convertible notes payable - related party		875,000
NET CASH PROVIDED BY FINANCING ACTIVITIES:	9,009,160	875,000
Net increase (decrease) in cash and cash equivalents	4,927,255	(7,877)
Cash and cash equivalents, beginning of period	133,435	18,412
Cash and cash equivalents, end of period	5,060,690	10,535
Supplemental cash flow disclosures:
Cash paid for interest	20,038
Accrued preferred dividends	160,219	320,000
Capital contributions - extinguishment of deferred compensation	434,065
Issuance of common stock for extinguishment of convertible note payable - related party and non-related party	10,352,219
Issuance of common stock for extinguishment of convertible note payable accrued interest - related party and non-related party	1,432,768
Issuance of common stock for extinguishment of dividends payable	4,773,480
Issuance of common stock for extinguishment of preferred stock A and preferred stock B	2,535
Deferred direct issuance costs - APIC	$ 145,974

Note 1 - Description of the Bus

Note 1 - Description of the Business and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	Note 1 Description of the Business Soliton, Inc. (“Soliton” or the “Company”) was organized under the laws of the State of Delaware on March 27, 2012. one first Initial Public Offering On February 19, 2019, 2,172,591 $5.00 $10,862,955 $9,700,000. $11,784,987 6,825,391 $4,773,480 954,696 2,534,766 127,500 14,613,000. not 4.99% 4.99% $47,781 273,034 not 4.99% not Going Concern The Company is an early stage and emerging growth company and has not For the three March 31, 2019 2018, $3,208,345 $1,351,665, $4,077,337 $878,997, March 31, 2019, $45,499,839, $3,329,660 $5,060,690. not one not The Company’s cash on hand of $5,060,690 March 31, 2019 not February 2020. no Basis of Presentation The accompanying condensed interim financial statements are unaudited. These unaudited interim financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. Accordingly, they do not 10 December 31, 2018 March 29, 2019. not may December 31, 2018 not Segments The Company operates in one Use of Estimates in Financial Statement Presentation The preparation of these financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The Company's significant estimates and assumptions include valuation of equity related instruments, depreciable lives of long-lived assets (including property and equipment and intangible assets), and the valuation allowance related to deferred taxes. Some of these judgments can be subjective and complex, and, consequently, actual results could differ from those estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates. Cash, Cash Equivalents and Restricted Cash The Company considers all highly liquid accounts with original maturities of three $250,000 may $250,000. Property and Equipment Property and equipment are stated at historical cost and depreciated on a straight-line basis over the estimated useful lives, generally three five Intangible Assets Intangible assets include trademarks. At March 31, 2019 December 31, 2018, $86,080 $84,942, not may three March 31, 2019 2018 $0 $376, Long-Lived Assets The Company evaluates its long-lived assets, including equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not . Deferred Rent Deferred rent is recorded and amortized to the extent the total minimum rental payments allocated to the current period on a straight-line basis differ from the cash payments required. Convertible Debt When conversion terms related to convertible debt would be triggered by future events not Fair Value Measurements Fair value is defined as the price which would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three Level 1 Level 2 1 not Level 3 At March 31, 2019 December 31, 2018, At March 31, 2019 December 31, 2018, not Deferred Direct Issuance Costs – Offering The Company had offering costs of $276,560, $250,000 $26,560 February 2019.  Warrants to Purchase Common Stock We accounted for warrants issued in connection with notes payable in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification (ASC) Topic 480 10, Distinguishing Liabilities from Equity three not not 470 20 25, Debt with Conversion and Other Options may Research and Development Expenses Research and development expenses are recognized as incurred and include the costs related to the Company's various contract research service providers, suppliers, engineering studies, supplies, outsourced testing and consulting, clinical costs, patent costs and salaries and related costs of employees working directly on research activities. Stock-Based Compensation Stock-based compensation expense includes the estimated fair value of equity awards vested during the reporting period. The expense for equity awards vested during the reporting period is determined based upon the grant date fair value of the award and is recognized as expense over the applicable vesting period of the stock award using the straight-line method. Income Taxes The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not not December 31, 2016 In assessing the realization of deferred tax assets, management considers whether it is more likely than not not March 31, 2019 December 31, 2018 not not no three March 31, 2019 2018. Management has evaluated and concluded that there were no March 31, 2019. not twelve The Company classifies interest expense and any related penalties related to income tax uncertainties as a component of income tax expense. No three March 31, 2019 2018. Net Loss per Common Share Basic net loss per common share is computed by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2019, 2,636,750 1,228,431 As of March 31, 2018, 15,000 2,534,766 305,000 JOBS Act Accounting Election The Company is an emerging growth company ("EGC"), as defined in the Jumpstart Our Business Startups Act of 2012 not may Subsequent Events The Company’s management reviewed all material events through the date that the financial statements were issued for subsequent event disclosure consideration. See Note 7 Recent Accounting Standards In February 2016, No. 2016 02, “Leases (Topic 842 12 December 15, 2019 may In June 2018, No. 2018 07, “Compensation Stock Compensation (Topic 718 No. 2018 07 not January 1, 2019 not three March 31, 2019. The Company does not not

Note 2 - Prepaid Expenses and O

Note 2 - Prepaid Expenses and Other Current Assets	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Prepaid Expenses and Other Current Assets [Text Block]	Note 2 - Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following: March 31, December 31, 2019 2018 Prepaid insurance $ 228,446 $ 9,453 Other receivables 2,436 1,080 Total prepaid expenses and other current assets $ 230,882 $ 10,533

Note 3 - Property and Equipment

Note 3 - Property and Equipment	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 3 - Property and Equipment Property and equipment consisted of the following: March 31, December 31, 2019 2018 Computer equipment and software $ 109,134 $ 105,704 Research and development equipment 244,480 244,480 Lab equipment 780,000 780,000 Leasehold improvements 242,167 242,167 Furniture 19,893 19,893 Subtotal 1,395,674 1,392,244 Less: accumulated depreciation (407,707 ) (378,004 ) Total property and equipment, net $ 987,967 $ 1,014,240 Depreciation expense for the three March 31, 2019 2018 $29,703 $30,185 , respectively.

Note 4 - Convertible Notes Paya

Note 4 - Convertible Notes Payable	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 4 - Convertible Notes Payable On February 19, 2019, $11,784,987 6,825,391 $4,773,480 954,696 not 4.99% 4.99% $47,781 273,034 not 4.99% not The total amount of issuance under the First Note and First Amendment throughout 2017 $5,000,000 $5,000,000 $944,063 1,585,086 March 31, 2019. On November 1, 2017, second $1,900,000 75% not $5,000,000 85% 8.25% June 29, 2018, 12.0% The Company closed the initial tranche of the Second Note on November 9, 2017 $400,000, December 1, 2017, $375,000, third December 26, 2017 $250,000, fourth January 8, 2018 $250,000, fifth January 25, 2018 $250,000 February 13, 2018 $375,000 $1,900,000. On June 29, 2018, April 30, 2019. As of March 31, 2019, $1,900,000 $1,900,000 $223,368 566,235 March 31, 2019. On April 2, 2018, August 10, 2018, $500,000 $0.175. not 4.99% 10.0% April 2, 2020 February 19, 2019. As of March 31, 2019, $500,000. $250,000 $250,000 four $452,219 $43,562 2,833,034 March 31, 2019. March 31, 2019, $47,781. On April 17, 2018, $3,000,000 $1.75. 10.0% two February 19, 2019. As of March 31, 2019, $3,000,000. $1,272,000 $1,728,000 $3,000,000 $221,775 1,841,036 March 31, 2019. The Company incurred issuance costs relating to the Fourth Note in the amount of $163,760, 24 $118,492 three March 31, 2019. The Company also issued warrants to purchase 91,350 $1.75 $103,006. 6. 24 $74,532 three March 31, 2019. On August 7, 2018, $485,000 10% five one $1.75 five $125,000 one On August 31, 2018, $200,000 August 7, 2018. December 21, 2018, $300,000 August 7, 2018 $985,000. October 2018 February 2019, $125,000 $860,000 February 15, 2019, $985,000 $20,038 The Company issued 685,000 2018. $775,616. $363,748 $66,423 $297,325 24 $325,955 three March 31, 2019. The Company issued 300,000 January February 2019. $285,234. $145,974 24 $145,974 three March 31, 2019.

Note 5 - Commitments and Contin

Note 5 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Commitments Contingencies and Guarantees [Text Block]	Note 5 - Commitments and Contingencies On April 5, 2012, 30 third MD Anderson has the right to terminate the agreement upon advanced notice in the event of a default by Soliton. The agreement will expire upon the expiration of the licensed intellectual property. The rights obtained by the Company pursuant to the agreement are made subject to the rights of the U.S. government to the extent that the technology covered by the licensed intellectual property was developed under a funding agreement between MD Anderson and the U.S. government. All out-of-pocket expenses incurred by MD Anderson in filing, prosecuting and maintaining the licensed patents have been and shall continue to be assumed by the Company. Leases The Company leases space for its corporate office, which provides for a five July 15, 2015, $8,053 three March 31, 2019 2018 $24,158 $16,793, Future minimum lease payments as of March 31, 2019 Year Ending December 31, Amount 2019 $ 78,573 2020 108,429 Thereafter 36,668 Total future minimum lease payments $ 223,670 Legal Proceedings In the normal course of business, from time-to-time, the Company may not

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 6 - Stockholders’ Deficit Preferred Stock The Company was authorized to issue 2,534,766 $0.001 may As of March 31, 2019 December 31, 2018, 0 416,666 0 2,118,100 The Series A preferred stock had the following features: 1. Dividends accrued at a rate of 8% $4.80 $24.00 $50,000,000 50.1% 2. A liquidation right preference over the right of the Company’s common stock. 3. Each share of the Series A preferred stock had one 4. Each share of the Series A preferred stock was convertible by the holder, at any time, into shares of common stock equal to $4.80 $4.80. The Series B preferred stock has similar rights as Series A preferred stock except that the dividends were based on $6.61 $6.61 $6.61. February 19, 2019 December 31, 2018, $4,773,480 $4,613,261, On February 14, 2019, 2,534,766 954,696 February 19, 2019 no Adoption of 2012 In November 2012, 2012 “2012 2012 may 2012 2012 2012 789,745 March 31, 2019, 14,745 2012 not 2012 2018 Adoption of 2018 In June 2018, 2018 2018 may 2018 2018 2018 3,000,000 March 31, 2019, 378,250 2018 Restricted Stock During the three March 31, 2019 2018, $264,453 $145,553, February 14, 2019, 127,500 no March 31, 2019. three March 31, 2018, no March 31, 2019, no Stock Options The following table summarizes stock option activities for the three March 31, 2019: Number of Weighted Weighted Aggregate Outstanding, December 31, 2018 2,235,000 $ 1.74 9.44 23,100 Granted 401,750 1.75 Exercised - - Cancelled - - Outstanding, March 31, 2019 2,636,750 $ 1.74 7.92 16,767,663 Exercisable, March 31, 2019 7,500 $ 0.13 8.51 $ 59,775 In January 2019, $484,000 September 30, 2018 three March 31, 2019, 401,750 $1.75 10 25% 1 $ 456,961 1 2. 53 % 2 5.27 two 3 84. 4 4 no 5 $1.67 All options issued and outstanding are being amortized over their respective vesting periods. The unrecognized compensation expense at March 31, 2019 $ 2,530,333 three March 31, 2019 2018, $247,592 $0, Warrants On April 20, 2018, 79,350 $1.75. April 20, 2023. On June 8, 2018, 12,000 $1.75. June 8, 2023. From October December 2018, 685,000 $1.75. five 300,000 $1.75 January February 2019. On February 19, 2019, five 152,081 $6.00. The grant date fair value of these 1,228,431 $1,636,232, 1 2.5% 2.8% 2 5 3 84% 85% 4 no 5 $1.67 February 19, 2019 $4.87 The fair value amount was included in discounts on convertible notes payable and being amortized over the life of the convertible notes payable. As a result of the Company’s IPO closing on February 14, 2019, $664,953 The following table summarizes warrant activities for the three March 31, 2019: Number of Weighted Weighted Aggregate Outstanding, December 31, 2018 776,350 $ 1.75 4.80 $ - Granted 452,081 3.18 Exercised - - Cancelled - - Outstanding, March 31, 2019 1,228,431 $ 2.28 4.66 $ 7,154,193 Exercisable, March 31, 2019 1,228,431 $ 2.28 4.66 $ 7,154,193

Note 7 - Subsequent Events

Note 7 - Subsequent Events	3 Months Ended
	Mar. 31, 2019
Notes to Financial Statements
Subsequent Events [Text Block]	Note 7 - Subsequent Events On May 8 , 2019, 87,500, 87,500 25,000 three April 15, 2019, April 15, 2019 April 29, 2019, 25,000 four 175,000 42 September 19, 2019.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2019
Accounting Policies [Abstract]
Initial Public Offering, Policy [Policy Text Block]	Initial Public Offering On February 19, 2019, 2,172,591 $5.00 $10,862,955 $9,700,000. $11,784,987 6,825,391 $4,773,480 954,696 2,534,766 127,500 14,613,000. not 4.99% 4.99% $47,781 273,034 not 4.99% not
Substantial Doubt about Going Concern [Policy Text Block]	Going Concern The Company is an early stage and emerging growth company and has not For the three March 31, 2019 2018, $3,208,345 $1,351,665, $4,077,337 $878,997, March 31, 2019, $45,499,839, $3,329,660 $5,060,690. not one not The Company’s cash on hand of $5,060,690 March 31, 2019 not February 2020. no
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying condensed interim financial statements are unaudited. These unaudited interim financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for interim financial information. Accordingly, they do not 10 December 31, 2018 March 29, 2019. not may December 31, 2018 not
Segment Reporting, Policy [Policy Text Block]	Segments The Company operates in one
Use of Estimates, Policy [Policy Text Block]	Use of Estimates in Financial Statement Presentation The preparation of these financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The Company's significant estimates and assumptions include valuation of equity related instruments, depreciable lives of long-lived assets (including property and equipment and intangible assets), and the valuation allowance related to deferred taxes. Some of these judgments can be subjective and complex, and, consequently, actual results could differ from those estimates. Although the Company believes that its estimates and assumptions are reasonable, they are based upon information available at the time the estimates and assumptions were made. Actual results could differ from those estimates.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash, Cash Equivalents and Restricted Cash The Company considers all highly liquid accounts with original maturities of three $250,000 may $250,000.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at historical cost and depreciated on a straight-line basis over the estimated useful lives, generally three five
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]	Intangible Assets Intangible assets include trademarks. At March 31, 2019 December 31, 2018, $86,080 $84,942, not may three March 31, 2019 2018 $0 $376,
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets The Company evaluates its long-lived assets, including equipment and intangible assets, for impairment whenever events or changes in circumstances indicate that the carrying value of these assets may not .
Deferred Rent [Policy Text Block]	Deferred Rent Deferred rent is recorded and amortized to the extent the total minimum rental payments allocated to the current period on a straight-line basis differ from the cash payments required.
Debt, Policy [Policy Text Block]	Convertible Debt When conversion terms related to convertible debt would be triggered by future events not
Fair Value Measurement, Policy [Policy Text Block]	Fair Value Measurements Fair value is defined as the price which would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. A three Level 1 Level 2 1 not Level 3 At March 31, 2019 December 31, 2018, At March 31, 2019 December 31, 2018, not
Deferred Direct Issuance Costs, Offering, Policy [Policy Text Block]	Deferred Direct Issuance Costs – Offering The Company had offering costs of $276,560, $250,000 $26,560 February 2019.
Warrants [Policy Text Block]	Warrants to Purchase Common Stock We accounted for warrants issued in connection with notes payable in accordance with Financial Accounting Standards Board ("FASB") Accounting Standards Codification (ASC) Topic 480 10, Distinguishing Liabilities from Equity three not not 470 20 25, Debt with Conversion and Other Options may
Research and Development Expense, Policy [Policy Text Block]	Research and Development Expenses Research and development expenses are recognized as incurred and include the costs related to the Company's various contract research service providers, suppliers, engineering studies, supplies, outsourced testing and consulting, clinical costs, patent costs and salaries and related costs of employees working directly on research activities.
Share-based Payment Arrangement [Policy Text Block]	Stock-Based Compensation Stock-based compensation expense includes the estimated fair value of equity awards vested during the reporting period. The expense for equity awards vested during the reporting period is determined based upon the grant date fair value of the award and is recognized as expense over the applicable vesting period of the stock award using the straight-line method.
Income Tax, Policy [Policy Text Block]	Income Taxes The Company uses the asset and liability method of accounting for income taxes. Under this method, deferred tax assets and liabilities are determined based on the differences between the financial reporting and the tax bases of reported assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company must then assess the likelihood that the resulting deferred tax assets will be realized. A valuation allowance is provided when it is more likely than not not December 31, 2016 In assessing the realization of deferred tax assets, management considers whether it is more likely than not not March 31, 2019 December 31, 2018 not not no three March 31, 2019 2018. Management has evaluated and concluded that there were no March 31, 2019. not twelve The Company classifies interest expense and any related penalties related to income tax uncertainties as a component of income tax expense. No three March 31, 2019 2018.
Earnings Per Share, Policy [Policy Text Block]	Net Loss per Common Share Basic net loss per common share is computed by dividing net loss available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net loss per common share is determined using the weighted-average number of common shares outstanding during the period, adjusted for the dilutive effect of common stock equivalents. In periods when losses are reported, the weighted-average number of common shares outstanding excludes common stock equivalents, because their inclusion would be anti-dilutive. As of March 31, 2019, 2,636,750 1,228,431 As of March 31, 2018, 15,000 2,534,766 305,000
JOBS Act Accounting Election [Policy Text Block]	JOBS Act Accounting Election The Company is an emerging growth company ("EGC"), as defined in the Jumpstart Our Business Startups Act of 2012 not may
Subsequent Events, Policy [Policy Text Block]	Subsequent Events The Company’s management reviewed all material events through the date that the financial statements were issued for subsequent event disclosure consideration. See Note 7
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Standards In February 2016, No. 2016 02, “Leases (Topic 842 12 December 15, 2019 may In June 2018, No. 2018 07, “Compensation Stock Compensation (Topic 718 No. 2018 07 not January 1, 2019 not three March 31, 2019. The Company does not not

Note 2 - Prepaid Expenses and_2

Note 2 - Prepaid Expenses and Other Current Assets (Tables)	3 Months Ended
	Mar. 31, 2019
Notes Tables
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	March 31, December 31, 2019 2018 Prepaid insurance $ 228,446 $ 9,453 Other receivables 2,436 1,080 Total prepaid expenses and other current assets $ 230,882 $ 10,533

Note 3 - Property and Equipme_2

Note 3 - Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2019
Notes Tables
Property, Plant and Equipment [Table Text Block]	March 31, December 31, 2019 2018 Computer equipment and software $ 109,134 $ 105,704 Research and development equipment 244,480 244,480 Lab equipment 780,000 780,000 Leasehold improvements 242,167 242,167 Furniture 19,893 19,893 Subtotal 1,395,674 1,392,244 Less: accumulated depreciation (407,707 ) (378,004 ) Total property and equipment, net $ 987,967 $ 1,014,240

Note 5 - Commitments and Cont_2

Note 5 - Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2019
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Year Ending December 31, Amount 2019 $ 78,573 2020 108,429 Thereafter 36,668 Total future minimum lease payments $ 223,670

Note 6 - Stockholders' Deficit

Note 6 - Stockholders' Deficit (Tables)	3 Months Ended
	Mar. 31, 2019
Notes Tables
Share-based Payment Arrangement, Option, Activity [Table Text Block]	Number of Weighted Weighted Aggregate Outstanding, December 31, 2018 2,235,000 $ 1.74 9.44 23,100 Granted 401,750 1.75 Exercised - - Cancelled - - Outstanding, March 31, 2019 2,636,750 $ 1.74 7.92 16,767,663 Exercisable, March 31, 2019 7,500 $ 0.13 8.51 $ 59,775
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number of Weighted Weighted Aggregate Outstanding, December 31, 2018 776,350 $ 1.75 4.80 $ - Granted 452,081 3.18 Exercised - - Cancelled - - Outstanding, March 31, 2019 1,228,431 $ 2.28 4.66 $ 7,154,193 Exercisable, March 31, 2019 1,228,431 $ 2.28 4.66 $ 7,154,193

Note 1 - Description of the B_2

Note 1 - Description of the Business and Summary of Significant Accounting Policies (Details Textual)	Feb. 19, 2019USD ($)$ / sharesshares	Mar. 31, 2019USD ($)shares	Mar. 31, 2018USD ($)shares	Dec. 31, 2018USD ($)shares
Stock Issued During Period, Shares, New Issues | shares	2,172,591
Shares Issued, Price Per Share | $ / shares	$ 5
Proceeds from Issuance of Common Stock	$ 10,862,955
Proceeds from Issuance of Common Stock, Net	9,700,000
Debt Conversion, Original Debt, Amount	$ 11,784,987
Debt Conversion, Converted Instrument, Shares Issued | shares	6,825,391
Conversion of Accrued Dividends into Common Stock, Amount Converted	$ 4,773,480
Conversion of Accrued Dividends into Common Stock, Shares Issued | shares	954,696
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares	127,500
Common Stock, Shares, Outstanding, Ending Balance | shares	14,613,000	14,613,000		1,998,056
Debt Instrument, Convertible, Threshold Percentage of Stock Ownership After Conversion	4.99%
Convertible Debt, Total	$ 47,781
Debt Instrument, Convertible, Number of Equity Instruments	273,034
Net Income (Loss) Attributable to Parent, Total		$ (3,208,345)	$ (1,351,665)
Net Cash Provided by (Used in) Operating Activities, Total		(4,077,337)	(878,997)
Retained Earnings (Accumulated Deficit), Ending Balance		(45,499,839)		$ (42,131,275)
Working Capital		3,329,660
Cash, Ending Balance		$ 5,060,690
Number of Operating Segments		1
Amortization of Intangible Assets, Total		$ 0	376
Deferred Direct Issuance Costs, Proposed Offering		276,560
Deferred Direct Issuance Costs, Proposed Offering, Previous Paid Through Accounts Payable		250,000
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs		186,029
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total		$ 0	$ 0
Incremental Common Shares Attributable to Share-based Payment Arrangements, Total | shares		2,636,750	15,000
Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares		1,228,431
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock | shares			2,534,766
Incremental Common Shares Attributable to Dilutive Effect of Nonvested Shares with Forfeitable Dividends | shares			305,000
Trademarks [Member]
Finite-Lived Intangible Assets, Gross, Total		$ 86,080		$ 84,942
Minimum [Member]
Property, Plant and Equipment, Useful Life		3 years
Maximum [Member]
Property, Plant and Equipment, Useful Life		5 years
Conversion of Preferred Stock into Common Stock [Member]
Conversion of Stock, Shares Issued | shares	2,534,766

Note 2 - Prepaid Expenses and_3

Note 2 - Prepaid Expenses and Other Current Assets - Prepaid Expenses and Other Current Assets (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Prepaid insurance	$ 228,446	$ 9,453
Other receivables	2,436	1,080
Total prepaid expenses and other current assets	$ 230,882	$ 10,533

Note 3 - Property and Equipme_3

Note 3 - Property and Equipment (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Depreciation, Total	$ 29,703	$ 30,185

Note 3 - Property and Equipme_4

Note 3 - Property and Equipment - Property and Equipment (Details) - USD ($)	Mar. 31, 2019	Dec. 31, 2018
Property and Equipment, Gross	$ 1,395,674	$ 1,392,244
Less: accumulated depreciation	(407,707)	(378,004)
Total property and equipment, net	987,967	1,014,240
Computer Equipment [Member]
Property and Equipment, Gross	109,134	105,704
Research and Development Equipment [Member]
Property and Equipment, Gross	244,480	244,480
Equipment [Member]
Property and Equipment, Gross	780,000	780,000
Leasehold Improvements [Member]
Property and Equipment, Gross	242,167	242,167
Furniture and Fixtures [Member]
Property and Equipment, Gross	$ 19,893	$ 19,893

Note 4 - Convertible Notes Pa_2

Note 4 - Convertible Notes Payable (Details Textual) - USD ($)	Feb. 19, 2019	Feb. 15, 2019	Dec. 21, 2018	Aug. 31, 2018	Aug. 10, 2018	Aug. 07, 2018	Feb. 13, 2018	Jan. 25, 2018	Jan. 08, 2018	Dec. 26, 2017	Dec. 01, 2017	Nov. 09, 2017	Nov. 01, 2017	Feb. 28, 2019	Jan. 31, 2019	Oct. 31, 2018	Mar. 31, 2019	Mar. 31, 2018	Feb. 13, 2018	Dec. 31, 2018	Feb. 14, 2019	Jun. 08, 2018	Apr. 20, 2018	Apr. 17, 2018
Debt Conversion, Original Debt, Amount	$ 11,784,987
Debt Conversion, Converted Instrument, Shares Issued	6,825,391
Conversion of Accrued Dividends into Common Stock, Amount Converted	$ 4,773,480
Conversion of Accrued Dividends into Common Stock, Shares Issued	954,696
Debt Instrument, Convertible, Threshold Percentage of Stock Ownership After Conversion	4.99%
Convertible Debt, Total	$ 47,781
Debt Instrument, Convertible, Number of Equity Instruments	273,034
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																	1,228,431
Class of Warrant or Right, Exercise Price of Warrants or Rights																	$ 2.28			$ 1.75
Warrants and Rights Outstanding																	$ 1,636,232
Interest Paid, Excluding Capitalized Interest, Operating Activities																	20,038
Amortization of Debt Discount (Premium)																	$ 664,953
Warrant Issued Under Fourth Note [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights																	91,350					12,000	79,350
Class of Warrant or Right, Exercise Price of Warrants or Rights																	$ 1.75					$ 1.75	$ 1.75
Warrants and Rights Outstanding																	$ 103,006
Debt Instrument, Unamortized Discount, Total																	74,532
Warrant Issued with Fifth Note [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights						1
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 1.75
Warrants and Rights Outstanding, Term						5 years
Warrants Issued in Connection with Fifth Note [Member]
Class of Warrant or Right, Issued During Period														300,000	300,000					685,000
Class of Warrant or Right, Issued During Period, Value																				$ 775,616
First Note [Member] | Convertible Debt [Member] | A Single Related Party [Member] | Conversion of Convertible Debt to Common Stock [Member]
Debt Conversion, Original Debt, Amount																	$ 5,000,000
Debt Conversion, Converted Instrument, Shares Issued																	1,585,086
Debt Conversion Accrued Interest Amount																	$ 944,063
Second Note [Member] | Convertible Debt [Member]
Debt Agreement, Maximum Borrowing Capacity													$ 1,900,000
Debt Instrument, Convertible, Percentage of Stock Price, Subsequent Equity Financing Gross Proceeds Note Less Than 5 Million													75.00%
Debt Instrument, Convertible, Percentage of Stock Price, Fully-diluted Common Shares													85.00%
Debt Instrument, Interest Rate, Stated Percentage													8.25%
Debt Instrument, Interest Rate, Maturity													12.00%
Proceeds from Issuance of Long-term Debt, Total							$ 375,000	$ 250,000	$ 250,000	$ 250,000	$ 375,000	$ 400,000							$ 1,900,000
Second Note [Member] | Convertible Debt [Member] | A Single Related Party [Member]
Debt Instrument, Face Amount																	1,900,000
Second Note [Member] | Convertible Debt [Member] | A Single Related Party [Member] | Conversion of Convertible Debt to Common Stock [Member]
Debt Conversion, Original Debt, Amount																	$ 1,900,000
Debt Conversion, Converted Instrument, Shares Issued																	566,235
Debt Conversion Accrued Interest Amount																	$ 223,368
Third Note [Member] | Convertible Debt [Member]
Debt Instrument, Convertible, Threshold Percentage of Stock Ownership After Conversion					4.99%
Debt Agreement, Maximum Borrowing Capacity					$ 500,000
Debt Instrument, Interest Rate, Stated Percentage					10.00%
Debt Instrument, Face Amount																	500,000
Debt Instrument, Convertible, Conversion Price					$ 0.175
Third Note [Member] | Convertible Debt [Member] | Non-related Party Investors [Member]
Debt Instrument, Face Amount																	250,000
Third Note [Member] | Convertible Debt [Member] | Conversion of Convertible Debt to Common Stock [Member] | Non-related Party Investors [Member]
Debt Conversion, Original Debt, Amount																	$ 452,219
Debt Conversion, Converted Instrument, Shares Issued																	2,833,034
Debt Conversion Accrued Interest Amount																	$ 43,562
Long-term Debt, Total																	47,781
Third Note [Member] | Convertible Debt [Member] | A Single Related Party [Member]
Debt Instrument, Face Amount																	250,000
Fourth Note [Member] | Convertible Debt [Member]
Debt Agreement, Maximum Borrowing Capacity																	3,000,000
Debt Instrument, Interest Rate, Stated Percentage																								10.00%
Debt Instrument, Face Amount																								$ 3,000,000
Debt Instrument, Convertible, Conversion Price																								$ 1.75
Debt Issuance Costs, Gross																	163,760
Debt Issuance Costs, Net, Total																	118,492
Fourth Note [Member] | Convertible Debt [Member] | Non-related Party Investors [Member]
Debt Instrument, Face Amount																	1,728,000
Fourth Note [Member] | Convertible Debt [Member] | Conversion of Convertible Debt to Common Stock [Member] | Non-related Party Investors [Member]
Debt Conversion, Original Debt, Amount																	$ 3,000,000
Debt Conversion, Converted Instrument, Shares Issued																	1,841,036
Debt Conversion Accrued Interest Amount																	$ 221,775
Fourth Note [Member] | Convertible Debt [Member] | Investor [Member]
Debt Instrument, Face Amount																	1,272,000
Fifth Note [Member] | Convertible Debt [Member]
Debt Instrument, Unamortized Discount, Total																					$ 664,953
Fifth Note [Member] | Non-convertible Promissory Notes [Member]
Debt Agreement, Maximum Borrowing Capacity			$ 985,000			$ 485,000
Debt Instrument, Interest Rate, Stated Percentage						10.00%
Proceeds from Issuance of Long-term Debt, Total						$ 125,000
Debt Issuance Costs, Net, Total																	285,234			363,748
Debt Agreement, Additional Borrowing Capacity			$ 300,000	$ 200,000
Proceeds from (Repayments of) Notes Payable, Total		$ 985,000
Interest Paid, Excluding Capitalized Interest, Operating Activities		$ 20,038
Amortization of Debt Discount (Premium)																	325,955
Fifth Note [Member] | Non-convertible Promissory Notes [Member] | Non-related Party Investors [Member]
Debt Issuance Costs, Net, Total																	145,974			297,325
Debt Instrument, Unamortized Discount, Total																	$ 145,974
Fifth Note [Member] | Non-convertible Promissory Notes [Member] | Related Party [Member]
Proceeds from Issuance of Long-term Debt, Total														$ 860,000		$ 125,000
Debt Issuance Costs, Net, Total																				$ 66,423

Note 5 - Commitments and Cont_3

Note 5 - Commitments and Contingencies (Details Textual) - office Space Lease Arrangement [Member] - USD ($)	Jul. 15, 2015	Mar. 31, 2019	Mar. 31, 2018
Lessee, Operating Lease, Term of Contract	5 years
Leases, Monthly Payment	$ 8,053
Operating Leases, Rent Expense, Net, Total		$ 24,158	$ 16,793

Note 5 - Commitments and Cont_4

Note 5 - Commitments and Contingencies - Future Minimum Lease Payments (Details)	Mar. 31, 2019USD ($)
2019	$ 78,573
2020	108,429
Thereafter	36,668
Total future minimum lease payments	$ 223,670

Note 6 - Stockholders' Defici_2

Note 6 - Stockholders' Deficit (Details Textual) - USD ($)	Feb. 19, 2019	Feb. 14, 2019	Jan. 31, 2019	Mar. 31, 2019	Mar. 31, 2018	Dec. 31, 2018	Jun. 30, 2018	Jun. 08, 2018	Apr. 20, 2018	Nov. 30, 2012
Preferred Stock, Shares Authorized						2,534,766
Preferred Stock, Par or Stated Value Per Share						$ 0.001
Dividends Payable				$ 160,219	$ 320,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	127,500
Extinguishment of Deferred Compensation, Amount			$ 484,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross				401,750
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price				$ 1.75
Share Price	$ 4.87
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				1,228,431
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 2.28		$ 1.75
Warrants and Rights Outstanding				$ 1,636,232
Convertible Debt [Member] | Fifth Note [Member]
Debt Instrument, Unamortized Discount, Total		$ 664,953
Measurement Input, Discount Rate [Member] | Minimum [Member]
Warrants and Rights Outstanding, Measurement Input				0.025
Measurement Input, Discount Rate [Member] | Maximum [Member]
Warrants and Rights Outstanding, Measurement Input				0.028
Measurement Input, Expected Term [Member]
Warrants and Rights Outstanding, Measurement Input				5
Measurement Input, Price Volatility [Member] | Minimum [Member]
Warrants and Rights Outstanding, Measurement Input				0.84
Measurement Input, Price Volatility [Member] | Maximum [Member]
Warrants and Rights Outstanding, Measurement Input				0.85
Measurement Input, Expected Dividend Payment [Member]
Warrants and Rights Outstanding, Measurement Input				0
Measurement Input, Share Price [Member]
Warrants and Rights Outstanding, Measurement Input				1.67
Warrant Issued Under Fourth Note [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights				91,350				12,000	79,350
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 1.75				$ 1.75	$ 1.75
Warrants and Rights Outstanding				$ 103,006
Debt Instrument, Unamortized Discount, Total				74,532
Fifth Note [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights			300,000			685,000
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 1.75			$ 1.75
Warrants and Rights Outstanding, Term						5 years
Warrants Issued to Underwriters [Member]
Class of Warrant or Right, Number of Securities Called by Warrants or Rights	152,081
Class of Warrant or Right, Exercise Price of Warrants or Rights	$ 6
Warrants and Rights Outstanding, Term	5 years
Restricted Stock [Member]
Share-based Payment Arrangement, Expense				264,453	$ 145,553
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		127,500			0
Share-based Payment Arrangement, Option [Member]
Share-based Payment Arrangement, Expense				$ 247,592	$ 0
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period				10 years
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage				25.00%
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period				1 year
Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture, Total				$ 456,961
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount Rate				2.53%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term				5 years 98 days
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				84.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments				$ 0
Share Price				$ 1.67
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total				$ 2,530,333
2012 Long Term Incentive Plan [Member]
Common Stock, Capital Shares Reserved for Future Issuance										789,745
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant						14,745
2018 Stock Plan [Member]
Common Stock, Capital Shares Reserved for Future Issuance							3,000,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant				378,250
Conversion of Preferred Stock To Common Stock [Member]
Conversion of Stock, Shares Issued		2,534,766
Conversion of Accrued Dividends Into Common Stock [Member]
Conversion of Stock, Shares Issued		954,696
Series A Preferred Stock [Member]
Preferred Stock, Shares Authorized						416,666
Preferred Stock, Par or Stated Value Per Share				$ 0.001		$ 0.001
Preferred Stock, Shares Outstanding, Ending Balance						416,666
Preferred Stock, Shares Issued, Total						416,666
Preferred Stock, Dividend Rate, Percentage				8.00%
Preferred Stock, Dividend Rate, Per-Dollar-Amount				$ 4.80
Preferred Stock, Dividend Payable, Share Price				$ 24
Preferred Stock, Dividend Payable, Gross Proceeds from Common Shares				$ 50,000,000
Preferred Stock, Dividend Payable, Percentage of Issued and Outstanding Shares				50.10%
Convertible Preferred Stock, Conversion Price						$ 4.80
Series B Preferred Stock [Member]
Preferred Stock, Shares Authorized						2,118,100
Preferred Stock, Par or Stated Value Per Share				$ 0.001		$ 0.001
Preferred Stock, Shares Outstanding, Ending Balance						2,118,100
Preferred Stock, Shares Issued, Total						2,118,100
Preferred Stock, Dividend Rate, Per-Dollar-Amount						$ 6.61
Convertible Preferred Stock, Conversion Price						$ 6.61
Dividends Payable				$ 4,773,480		$ 4,613,261

Note 6 - Stockholders' Defici_3

Note 6 - Stockholders' Deficit - Stock Options (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Outstanding, Number of Shares (in shares)	2,235,000
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.74
Outstanding, Weighted Average Remaining Life (Year)	7 years 335 days	9 years 160 days
Outstanding, Aggregate Intrinsic Value	$ 16,767,663	$ 23,100
Granted, Number of Shares (in shares)	401,750
Granted, Weighted Average Exercise Price (in dollars per share)	$ 1.75
Outstanding, Number of Shares (in shares)	2,636,750	2,235,000
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 1.74	$ 1.74
Exercisable, Number of Shares (in shares)	7,500
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 0.13
Exercisable, Weighted Average Remaining Life (Year)	8 years 186 days
Exercisable, Aggregate Intrinsic Value	$ 59,775

Note 6 - Stockholders' Defici_4

Note 6 - Stockholders' Deficit - Warrants (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2019	Dec. 31, 2018
Warrant outstanding, shares (in shares)	776,350
Warrant outstanding, weighted average exercise price (in dollars per share)	$ 1.75
Warrant outstanding, weighted average remaining contractual term (Year)	4 years 240 days	4 years 292 days
Warrant granted, shares (in shares)	452,081
Warrant granted, weighted average exercise price (in dollars per share)	$ 3.18
Warrant outstanding, shares (in shares)	1,228,431	776,350
Warrant outstanding, weighted average exercise price (in dollars per share)	$ 2.28	$ 1.75
Warrant outstanding, aggregate intrinsic value	$ 7,154,193
Warrant exercisable, shares (in shares)	1,228,431
Warrant exercisable, weighted average exercise price (in dollars per share)	$ 2.28
Warrant exercisable, weighted average remaining contractual term (Year)	4 years 240 days
Warrant exercisable, aggregate intrinsic value	$ 7,154,193

Note 7 - Subsequent Events (Det

Note 7 - Subsequent Events (Details Textual) - Restricted Stock [Member] - Subsequent Event [Member] - shares	May 08, 2019	May 01, 2019
Share-based Payment Arrangement, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period		25,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	120 days
Share-based Payment Arrangement, Tranche Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	175,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years 180 days
Consultant One [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	87,500
Consultant Two [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	87,500
Consultant Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	25,000